For example, the mutations in BRCA1 and BRCA2 in serous ovarian cancer were identified as primary cancer drivers, along with mutations in the tumor-suppressor genes like TP53, NF1, RB1, and PTEN [34,35]. This evidence concerns the gene TP53 and neoplasm.